Lysosomal Storage Disorders

CE / CME

Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: December 12, 2022

Expiration: December 11, 2023

Sarah Viall
Sarah Viall, MSN, PPCNP-BC
Neal Weinreb
Neal Weinreb, MD, FACP

Pretest

Progress
1 2
Course Completed
1.
Which of the following is consistent with all lysosomal storage disorders (LSDs)?
2.

Which of the following is an appropriate biomarker to help determine the presence of Gaucher’s disease?

3.

In enzyme replacement therapy, what most distinguishes second-generation from first-generation agents?

4.

How often do you currently obtain a detailed family history from a new patient?

5.

How often do you currently consider an LSD diagnosis when presented with symptoms that could represent any of several disorders?

6.

How often do you currently discuss positive changes with patients on treatment for an LSD?